Keyphrases
Alkylating Chemotherapy
80%
Astrocytoma
100%
Clinical Outcomes
20%
Cox Regression Analysis
20%
Heterogeneous Groups
20%
IDH-mutant Astrocytoma
20%
IDH-mutant Glioma
40%
Isocitrate Dehydrogenase 1 (IDH1)
100%
Kaplan-Meier Method
20%
Multivariable
40%
Oligodendroglioma
100%
Optimal Management
20%
Overall Survival
80%
Practice Patterns
20%
Progression-free Survival
80%
Radiation Survey
20%
Radiation Therapy
80%
Re-irradiation
60%
Retreatment
20%
Salvage Surgery
20%
Salvage Therapy
100%
Survival Median
40%
Systemic Therapy
60%
Tertiary Cancer Center
20%
Treatment Strategy
20%
Well-defined
20%
Medicine and Dentistry
Chemotherapy
66%
Ganglioglioma
33%
Isocitrate Dehydrogenase
100%
Kaplan Meier Method
16%
Malignant Neoplasm
16%
Oligoastrocytoma
100%
Oligodendroglioma
100%
Overall Survival
66%
Progression Free Survival
66%
Proportional Hazards Model
16%
Radiation Therapy
66%
Re-Irradiation
50%
Retreatment
16%
Salvage Therapy
100%
Systemic Therapy
50%
Pharmacology, Toxicology and Pharmaceutical Science
Astrocytoma
100%
Chemotherapy
66%
Isocitrate Dehydrogenase
100%
Malignant Neoplasm
16%
Oligodendroglioma
100%
Overall Survival
66%
Progression Free Survival
66%
Neuroscience
Astrocytoma
100%
Isocitrate Dehydrogenase
100%
Oligodendroglioma
100%
Radiation Therapy
66%